Long-Acting Antipsychotic Sampling Program In Hospitals Cleared By OIG Advisory Opinion

Sample program focuses only on inpatient use and in hospitals that do not accept Prescription Drug Marketing Act-compliant trial units. By improving adherence, program could lower federal health care costs over time, Office of Inspector General suggests.